Publications

• 1. Rahman SM
  2. Bowden A
  3. Green CB
  4. Pentland AP
  5. Richardson CT
  6. DeBenedetto A
  7. Plovanich M
  8. Wolf JR
  Identifying Care Gaps and Referral Patterns in Acute Dermatology at Urgent Care Centers.; Research square. 2024 Aug 14.
• 1. Guy DR
  2. Mizes A
  3. Richardson CT
  Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib.; JAAD case reports; Vol 47, pp. 47-49. 2024 Mar 15.
• 1. Kowalski EH
  2. Kenney HM
  3. Richardson CT
  Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin.; JAAD case reports; Vol 41, pp. 26-29. 2023 Sep 09.
• 1. Narayan N
  2. Richardson CT
  Serologic differences between dermatomyositis and antisynthetase syndrome using a commercially available autoantibody panel: a retrospective cohort study.; Journal of the American Academy of Dermatology. 2023 Jun 28.
• 1. Kowalski EH
  2. Stolarczyk A
  3. Richardson CT
  Successful treatment of severe chronic cutaneous lupus with anifrolumab: A series of 6 cases.; JAAD case reports; Vol 37, pp. 21-29. 2023 May 04.
• 1. Shah S
  2. Esaa FS
  3. Baughman L
  4. Gadarowski MB
  5. Richardson CT
  Differential effect of the 2019 EULAR/ACR classification criteria for systemic lupus on different cutaneous lupus subtypes.; Journal of the American Academy of Dermatology. 2023 Feb 03.
• 1. Yon J
  2. Curran T
  3. Richardson CT
  Lack of cutaneous B cells differentiates lupus-like skin disease in MRL/lpr mice from human discoid lupus.; The Journal of investigative dermatology. 2023 Jan 13.
• 1. Narayan N
  2. Richardson CT
  Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature.; JAAD case reports; Vol 25, pp. 72-74. 2022 Jun 03.
• 1. Lerman I
  2. Bawany F
  3. Whitt W
  4. Esaa F
  5. Yon J
  6. Babkowski N
  7. Rapp MB
  8. Scott GA
  9. Anolik JH
  10. Richardson CT
  Prominent B cell signature differentiates discoid from subacute cutaneous lupus erythematosus.; The Journal of investigative dermatology. 2022 May 17.
• 1. Kaur J
  2. Zambito J
  3. Richardson CT
  Methotrexate injection site reactions: Case report and literature review.; JAAD case reports; Vol 23. 2022 May.
• 1. Lee G
  2. Scott GA
  3. Munsiff SS
  4. Richardson CT
  Locally recurrent primary cutaneous coccidioidomycosis.; JAAD case reports; Vol 16. 2021 Oct.
• 1. Lerman I
  2. Mitchell DC
  3. Richardson CT
  Human cutaneous B cells: what do we really know?; Annals of translational medicine; Vol 9(5). 2021 Mar.
• 1. Pukhalskaya T
  2. Stiegler J
  3. Scott G
  4. Richardson CT
  5. Smoller B
  Degos Disease (Malignant Atrophic Papulosis) With Granular IgM on Direct Immunofluorescence.; Cureus; Vol 13(1). 2021 Jan 13.
• 1. Dean O
  2. Cusick EH
  3. Grover R
  4. Mercurio MG
  5. Richardson CT
  Congenital absence of the skin secondary to the self-improving subtype of dystrophic epidermolysis bullosa with recurrent lesions throughout early childhood.; JAAD case reports; Vol 7. 2021 Jan.
• 1. Bawany F
  2. Tbakhi B
  3. Mendler JH
  4. Richardson CT
  5. Bennett JM
  6. Aljitawi OS
  Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.; Blood advances; Vol 4(22). 2020 Nov 24.
• 1. Whitt W
  2. Stiegler JD
  3. Richardson CT
  Autoimmune progesterone dermatitis mimicking facial erythromelalgia successfully treated with hysterectomy and bilateral salpingo-oophorectomy.; JAAD case reports; Vol 6(10). 2020 Oct.
• 1. Moran MC
  2. Beck LA
  3. Richardson CT
  A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.; The Journal of investigative dermatology; Vol 140(5). 2020 May.
• 1. Mitchell DC
  2. Agnihothri R
  3. Scott GA
  4. Korman B
  5. Richardson CT
  A case of concurrent systemic sclerosis and scleredema.; JAAD case reports; Vol 5(11). 2019 Nov.
• 1. Lerman I
  2. Agnihothri R
  3. Scott GA
  4. Richardson CT
  An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus.; JAAD case reports; Vol 5(11). 2019 Nov.
• 1. Lerman I
  2. Richardson CT
  Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment.; Cureus; Vol 11(9). 2019 Sep 26.
• 1. Dziwis J
  2. Agnihothri R
  3. Lieberman A
  4. Richardson CT
  A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma.; JAAD case reports; Vol 5(9). 2019 Sep.
• 1. Richardson CT
  2. Slack MA
  3. Dhillon G
  4. Marcus CZ
  5. Barnard J
  6. Palanichamy A
  7. Sanz I
  8. Looney RJ
  9. Anolik JH
  Failure of B Cell Tolerance in CVID.; Frontiers in immunology; Vol 10. 2019.
• 1. Richardson CT
  2. Hayden MS
  3. Gilmore ES
  4. Poligone B
  Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure.; American journal of clinical dermatology; Vol 19(1). 2018 Feb.
• 1. Rapp M
  2. Pentland A
  3. Richardson C
  Successful Treatment of Pemphigus Vulgaris With Ofatumumab; Journal of drugs in dermatology : JDD; Vol 17(12). 2018 Jan 01.
• 1. Alexander-Savino CV
  2. Hayden MS
  3. Richardson C
  4. Zhao J
  5. Poligone B
  Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.; Oncotarget; Vol 7(46). 2016 Nov 15.
• 1. Jenks SA
  2. Palmer EM
  3. Marin EY
  4. Hartson L
  5. Chida AS
  6. Richardson C
  7. Sanz I
  9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.; Arthritis and rheumatism; Vol 65(12). 2013 Dec.
• 1. Richardson C
  2. Chida AS
  3. Adlowitz D
  4. Silver L
  5. Fox E
  6. Jenks SA
  7. Palmer E
  8. Wang Y
  9. Heimburg-Molinaro J
  10. Li QZ
  11. Mohan C
  12. Cummings R
  13. Tipton C
  14. Sanz I
  Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.; Journal of immunology (Baltimore, Md. : 1950); Vol 191(10). 2013 Nov 15.